Net loss of Trident Texofab reported to Rs 0.10 crore in the quarter ended March 2024 as against net profit of Rs 0.06 crore during the previous quarter ended March 2023. Sales rose 24.46% to Rs 30.17 crore in the quarter ended March 2024 as against Rs 24.24 crore during the previous quarter ended March 2023.For the full year,net profit declined 51.35% to Rs 1.08 crore in the year ended March 2024 as against Rs 2.22 crore during the previous year ended March 2023. Sales rose 3.24% to Rs 99.48 crore in the year ended March 2024 as against Rs 96.36 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales30.1724.24 24 99.4896.36 3 OPM %3.382.23 -6.196.55 - PBDT-0.070.34 PL 2.514.50 -44 PBT-0.48-0.07 -586 0.862.86 -70 NP-0.100.06 PL 1.082.22 -51 Powered by Capital Market - Live News

Trident Texofab has revised the meeting of the Board of Directors which was scheduled to be held on 21 May 2024. The meeting will now be held on 25 May 2024.Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 21 May 2024Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 13 March 2024.Powered by Capital Market - Live News

Net profit of Trident Texofab declined 51.30% to Rs 0.56 crore in the quarter ended December 2023 as against Rs 1.15 crore during the previous quarter ended December 2022. Sales declined 6.27% to Rs 23.01 crore in the quarter ended December 2023 as against Rs 24.55 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales23.0124.55 -6 OPM %8.268.84 - PBDT1.081.99 -46 PBT0.671.59 -58 NP0.561.15 -51 Powered by Capital Market - Live News